February 4, 2020 – “Commercializing innovation for cancer patients and economic impact”, February 4, 2020
Category: Uncategorized
FACIT Features: Fusion Pharma Attracts $20M USD Commitment from Canada Pension Plan Investment Board
January 13, 2020 – January 13, 2020 – The financing enables the company to continue leveraging strong Ontario science, as well as develop manufacturing and local career opportunities for scientists and trainees
FACIT Features: Turnstone Biologics Partners with Takeda on viral immunotherapies for cancer
December 19, 2019 – December 19, 2019 – The strategic collaboration will focus on developing multiple products from Turnstone’s next-gen oncolytic viral immunotherapies, marking an important alliance for both companies in the fight against cancer.
FACIT Features: OICR's Dr. Trevor Pugh wins $1M award for early cancer detection
December 5, 2019 – December 5, 2019 – The $1M award will support Dr. Pugh’s development work towards advancing a blood-based diagnostic for early cancer detection, in collaboration with Dr. Raymond Kim of the Princess Margaret Cancer Centre.
Read More from FACIT Features: OICR's Dr. Trevor Pugh wins $1M award for early cancer detection
FACIT, Triphase Accelerator, Celgene, and OICR to present at Canadian Science Policy Conference 2019
November 8, 2019 – November 8, 2019 – Titled “Ontario First in the innovation economy: impacts of a $1B USD public-private-partnership (PPP) on Canadian healthcare commercialization”, the panel seeks to highlight the outcomes and key lessons from this unprecedented partnership.
FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research
November 6, 2019 – November 6, 2019 – Scaling FACIT’s impact requires new partners and expanded expertise in the management of investments and equity markets. To that end, FACIT has recruited two seasoned executives through its Executive-in-Residence (EIR) Program.
FACIT and University of Toronto launch precision medicine company: Cellular Analytics
October 30, 2019 – October 30, 2019 – Cellular Analytics is founded upon a proprietary microfluidic platform that enables molecular characterization of cancer at the level of single circulating tumour cells.
Read More from FACIT and University of Toronto launch precision medicine company: Cellular Analytics
FACIT Features: Portfolio company KA Imaging secures Series A financing and new global strategic partner
October 24, 2019 – October 24, 2019 – New partnership will provide the Ontario-based start up with both capital and advanced manufacturing expertise to accelerate its portable multi-energy x-ray detector technology.
FACIT’s Prospects Oncology Fund invests in Ontario-developed medical device and novel therapeutic platform technologies
September 26, 2019 – September 26, 2019 – FACIT announces investments in Xpan Inc. and innovations from OICR and the University of Toronto
FACIT Features: OICR, Thermo Fisher Scientific & Genome Canada announce commercial partnership
August 8, 2019 – August 8, 2019 – New collaboration will develop targeted next generation sequencing (NGS) assays and software to improve cancer management